Back to top
more

Ingevity (NGVT)

(Delayed Data from NYSE)

$45.15 USD

45.15
151,093

+0.71 (1.60%)

Updated Jul 22, 2024 04:00 PM ET

After-Market: $45.14 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Chemical - Specialty

Better trading starts here.

Zacks News

Venator (VNTR) Surges: Stock Moves 6.9% Higher

Venator (VNTR) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Anindya Barman headshot

4 Chemical Specialty Stocks to Escape Industry Challenges

Soft demand amid sluggish industrial activities due to coronavirus clouds prospects for the Zacks Chemicals Specialty industry. Quaker Chemical (KWR), Valvoline (VVV), Element Solutions (ESI) and Ingevity (NGVT) are set to gain from self-help actions.

Ingevity (NGVT) Up 12% Since Last Earnings Report: Can It Continue?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why You Should Add Ingevity (NGVT) Stock to Your Portfolio

Ingevity (NGVT) benefits from regulation-driven adoption of its applications and cost-reduction measures.

Ingevity (NGVT) Q3 Earnings and Revenues Beat Estimates

Ingevity (NGVT) delivered earnings and revenue surprises of 82.65% and 6.71%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Ingevity (NGVT) Up 44% in 6 Months: What's Behind the Rally?

Ingevity (NGVT) benefits from its cost-management actions and regulation-driven demand for its applications.

Anindya Barman headshot

Ingevity Gains on Cost Actions Amid Weak Industrial Demand

Ingevity (NGVT) benefits from cost-reduction measures and growth in its applications driven by regulations and technology adoption.

Why You Should Keep Ingevity (NGVT) Stock in Your Portfolio

While Ingevity (NGVT) faces headwind from soft demand in industrial specialties and oilfield technologies, it should gain from cost actions and regulation-driven adoption of its applications.

Ingevity (NGVT) Up 57% in 6 Months: What's Driving the Stock?

Ingevity (NGVT) benefits from its cost-saving actions and growth in its applications driven by regulations and technology adoption.

Why Is Ingevity Corporation (NGVT) Up 1.4% Since Last Earnings Report?

Ingevity Corporation (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold Onto Ingevity (NGVT) Stock for Now

While Ingevity (NGVT) is exposed to weakness in industrial specialties and oilfield technologies businesses, it should gain from strong demand for activated carbon products in China and cost actions.

Ingevity (NGVT) Earnings Meet, Sales Beat Estimates in Q2

Ingevity's (NGVT) Q2 revenues decline year over year on account of weaker demand, fuelled by the economic impacts of the coronavirus pandemic.

Ingevity Corporation (NGVT) Matches Q2 Earnings Estimates

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 0.00% and 7.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Ingevity Corporation (NGVT) Q2 Earnings Expected to Decline

Ingevity Corporation (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Anindya Barman headshot

Chemical Specialty Industry Outlook Bleak on Muted Demand

Weak demand and raw material supply disruptions due to coronavirus pose as headwinds to the chemical specialty industry.

Why You Should Retain Ingevity (NGVT) Stock in Your Portfolio

While Ingevity (NGVT) is exposed to weakness in industrial specialties, it should gain from the Capa acquisition.

Ingevity to Lower Costs in Response to Coronavirus Outbreak

Ingevity's (NGVT) cost-reduction measures will allow it to stay within the revised guidance range set out in its earnings release for the first quarter of 2020.

Ingevity Corporation (NGVT) Up 3.1% Since Last Earnings Report: Can It Continue?

Ingevity Corporation (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ingevity Gains on Capa Buyout Amid Weak Industrial Demand

While Ingevity (NGVT) is exposed to weakness in industrial specialties, it is gaining from the Capa acquisition.

Ingevity (NGVT) Earnings & Revenues Surpass Estimates in Q1

Ingevity (NGVT) expects sales for 2020 to be between $1.1 billion and $1.2 billion.

Ingevity Corporation (NGVT) Beats Q1 Earnings and Revenue Estimates

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 33.33% and 9.99%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Ingevity Corporation (NGVT) Q1 Earnings Expected to Decline

Ingevity Corporation (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingevity to Gain From Capa Buyout & Regulation-driven Demand

While Ingevity (NGVT) is exposed to cost pressures, and weakness in industrial specialties and oilfield applications, it should gain from the Capa acquisition.

Here's Why You Should Hold Onto Ingevity (NGVT) Stock Now

Let's find out why specialty chemicals and materials maker Ingevity (NGVT) is worth retaining at the moment.

Ingevity Provides Update in Response to Coronavirus Outbreak

Ingevity's (NGVT) first quarter is going better than anticipated despite modest headwinds from the coronavirus outbreak.